PAPER Rancillac A, Geoffroy H, Rossier J
SEARCH RESULTS
330988 RESULTS
PAPER Perri R, Zannino G, Caltagirone C, Carlesimo GA
Alzheimer's disease and semantic deficits: A feature-listing study.
Neuropsychology. 2012 Sep;26(5):652-63. PubMed: 22799748PAPER Ge T, Feng J, Hibar DP, Thompson PM, Nichols TE
Increasing power for voxel-wise genome-wide association studies: The random field theory, least square kernel machines and fast permutation procedures.
Neuroimage. 2012 Nov 1;63(2):858-73. PubMed: 22800732PAPER Amiraslani B, Sabouni F, Abbasi S, Nazem H, Sabet M
Recognition of betaine as an inhibitor of lipopolysaccharide-induced nitric oxide production in activated microglial cells.
Iran Biomed J. 2012;16(2):84-9. PubMed: 22801281PAPER Kalaria RN
Risk factors and neurodegenerative mechanisms in stroke related dementia.
Panminerva Med. 2012 Sep;54(3):139-48. PubMed: 22801431PAPER de la Monte SM
Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.
Panminerva Med. 2012 Sep;54(3):171-8. PubMed: 22801434PAPER Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, Behrens TW, Magnusson OT, Kong A, Thorsteinsdottir U, Watts RJ, Stefansson K
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
Nature. 2012 Aug 2;488(7409):96-9. PubMed: 22801501PAPER Snellman A, Rokka J, Lopez-Picon FR, Eskola O, Wilson I, Farrar G, Scheinin M, Solin O, Rinne JO, Haaparanta-Solin M
Pharmacokinetics of [(18)F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1784-95. PubMed: 22801729PAPER Liu XA, Song J, Jiang Q, Wang Q, Tian Q, Wang JZ
Expression of the hyperphosphorylated tau attenuates ER stress-induced apoptosis with upregulation of unfolded protein response.
Apoptosis. 2012 Oct;17(10):1039-49. PubMed: 22802092PAPER
Correction for Frieden and Garai, Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease.
Nat Struct Mol Biol. 2008 Aug;15(8):819-26. PubMed: 22802665PAPER Kaidanovich-Beilin O, Cha DS, McIntyre RS
Crosstalk between metabolic and neuropsychiatric disorders.
F1000 Biol Rep. 2012;4:14. PubMed: 22802875PAPER Lai AY, McLaurin J
Inhibition of amyloid-beta peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer disease.
Biochim Biophys Acta. 2012 Oct;1822(10):1629-37. PubMed: 22800931PAPER Willander H, Presto J, Askarieh G, Biverstål H, Frohm B, Knight SD, Johansson J, Linse S
BRICHOS Domains Efficiently Delay Fibrillation of Amyloid β-Peptide.
J Biol Chem. 2012 Sep 7;287(37):31608-17. PubMed: 22801430PAPER Sierra C
Cerebral small vessel disease, cognitive impairment and vascular dementia.
Panminerva Med. 2012 Sep;54(3):179-88. PubMed: 22801435PAPER Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM, Ferm M, Dean RA, Simon AJ, Swenson F, Siuciak JA, Kaplow J, Thambisetty M, Zagouras P, Koroshetz WJ, Wan HI, Trojanowski JQ, Shaw LM,
Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease.
Arch Neurol. 2012 Jul 16;:1-8. PubMed: 22801723Current Filters
No filters selected